patchmaster software with heka epc10 (HEKA Electronics Incorporated)
90
Structured Review
HEKA Electronics Incorporated
patchmaster software with heka epc10
Patchmaster Software With Heka Epc10, supplied by HEKA Electronics Incorporated, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/patchmaster+software+(heka+epc10)/epc+10+amplifier/us12303496-590-7-9
Average 90 stars, based on 1 article reviews
Patchmaster Software With Heka Epc10, supplied by HEKA Electronics Incorporated, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/patchmaster+software+(heka+epc10)/epc+10+amplifier/us12303496-590-7-9
Average 90 stars, based on 1 article reviews
patchmaster software with heka epc10 - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Membrane:Article Title: In Vitro and In Vivo Pharmacological Characterization of a Novel TRPM8 Inhibitor Chemotype Identified by Small-Scale Preclinical Screening Article Snippet: Data were sampled at 10 Article Title: Highly functionalized β-lactams and 2-ketopiperazines as TRPM8 antagonists with antiallodynic activity Article Snippet: Data were sampled at 10 Article Title: New TRPM8 blockers exert anticancer activity over castration-resistant prostate cancer models. Article Snippet: TRPM8 has recently emerged as a druggable target in prostate cancer (PC) and TRPM8 modulators have been proposed as potential anticancer agents in this pathology.. We have recently demonstrated their effectiveness in a castration-resistant prostate cancer (CRPC) model that is usually resistant to androgen deprivation therapy (ADT) and is considered the most aggressive form of PC.. This is why the discovery of selective, effective, and potent TRPM8 modulators would improve the molecular arsenal in support of PC standard-of-care treatments. Article Title: β–Lactam TRPM8 Antagonist RGM8-51 Displays Antinociceptive Activity in Different Animal Models Article Snippet: The membrane potential was measured in the absence and the presence of compound RGM8-51 at 10 μM in a time interval of 1 min. Data were sampled at 10 Article Title: Phenylalanine-Derived β-Lactam TRPM8 Modulators. Configuration Effect on the Antagonist Activity Article Snippet: The membrane potential was measured in the absence and the presence of compounds 14 and 16 at 10 μM in a time interval of 1 min. Data were sampled at 10 Article Title: Synthesis, high-throughput screening and pharmacological characterization of β–lactam derivatives as TRPM8 antagonists Article Snippet: Data were sampled at 10 Software:Article Title: In Vitro and In Vivo Pharmacological Characterization of a Novel TRPM8 Inhibitor Chemotype Identified by Small-Scale Preclinical Screening Article Snippet: Data were sampled at 10 Article Title: Highly functionalized β-lactams and 2-ketopiperazines as TRPM8 antagonists with antiallodynic activity Article Snippet: Data were sampled at 10 Article Title: New TRPM8 blockers exert anticancer activity over castration-resistant prostate cancer models. Article Snippet: TRPM8 has recently emerged as a druggable target in prostate cancer (PC) and TRPM8 modulators have been proposed as potential anticancer agents in this pathology.. We have recently demonstrated their effectiveness in a castration-resistant prostate cancer (CRPC) model that is usually resistant to androgen deprivation therapy (ADT) and is considered the most aggressive form of PC.. This is why the discovery of selective, effective, and potent TRPM8 modulators would improve the molecular arsenal in support of PC standard-of-care treatments. Article Title: β–Lactam TRPM8 Antagonist RGM8-51 Displays Antinociceptive Activity in Different Animal Models Article Snippet: The membrane potential was measured in the absence and the presence of compound RGM8-51 at 10 μM in a time interval of 1 min. Data were sampled at 10 Article Title: Phenylalanine-Derived β-Lactam TRPM8 Modulators. Configuration Effect on the Antagonist Activity Article Snippet: The membrane potential was measured in the absence and the presence of compounds 14 and 16 at 10 μM in a time interval of 1 min. Data were sampled at 10 Article Title: Synthesis, high-throughput screening and pharmacological characterization of β–lactam derivatives as TRPM8 antagonists Article Snippet: Data were sampled at 10 |